The condition requires lifelong surgeries, including a heart and liver transplant every ten years, which Ariella will likely ...

Hypoplastic Left Heart Syndrome (HLHS ... B™ achieved 100% transplant-free survival up to five years post-Glenn surgery. This represents a significant improvement compared to historical ...

“Throughout 2024, we continued to advance the development of our investigational cellular therapy candidate, Lomecel-B™, as a potential treatment for both Hypoplastic Left Heart ...

"Throughout 2024, we continued to advance the development of our investigational cellular therapy candidate, Lomecel-B™, as a potential treatment for both Hypoplastic Left Heart Syndrome, or HLHS, and ...

Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication ...

gstt.sthames.nhs.uk Objective: To assess the frequency of systemic venous collaterals to the atria, which may cause desaturation, after stage II reconstructive surgery for hypoplastic left heart ...

Aims We sought to explore what parents value from their physicians when deciding on treatment for Hypoplastic Left Heart Syndrome (HLHS). We were interested in parental views on the decision-making ...

Congenital heart disease (CHD) is one of the most common birth defects, but the full extent of its genetic underpinnings has ...

Hypertrophic Cardiomyopathy (HCM), also called Thick Heart Syndrome, is a genetic condition where the heart muscle becomes too thick, making it harder for the heart to pump blood properly.